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Measuring bothersome menopausal
symptoms: development and validation of
the MenoScores questionnaire
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Abstract
Background: The experience of menopausal symptoms is common and an adequate patient-reported outcome
measure is crucial in studies where women are treated for these symptoms. The aims of this study were to identify
a patient-reported outcome measure for bothersome menopausal symptoms and, in the absence of an adequate
tool, to develop a new measure with high content validity, and to validate it using modern psychometric methods.
Methods: The literature was reviewed for existing questionnaires and checklists for bothersome menopausal
symptoms. Relevant items were extracted and subsequently tested in group interviews, single interviews, and pilot
tests. A patient-reported outcome measure was drafted and completed by 1504 women. Data was collected and
psychometrically validated using item-response theory Rasch Models.
Results: All questionnaires identified in the literature lacked content validity regarding bothersome menopausal
symptoms and none were validated using item-response theory. Our content validation resulted in a draft
measurement encompassing 122 items across eight domains. Following psychometrical validation, the final version
of our patient-reported outcome measure, named the MenoScores Questionnaire, encompassed 51 items, including
one single item, covering 11 scales.
Conclusion: Menopausal symptoms are multidimensional with some symptoms unquestionably related to the
menopausal transition. We identified four constructs of importance: hot flushes, day-and-night sweats, general
sweating, and menopausal-specific sleeping problems. The MenoScores Questionnaire is condition-specific with
high content validity and adequate psychometrical properties. It is designed to measure bothersome menopausal
symptoms and all scales are developed and psychometrically validated using item-response theory Rasch Models.
Trial registration: Approved by the Danish Data Agency (J.nr. 2015–41-4057). Ethics Committee approval was not
required.
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Background
Menopause is the cessation of women’s menstruation
and can be determined retrospectively 12 months after
the final menstrual period (FMP) [1, 2]. On average,
women experience the menopausal transition in their
mid-to-late forties [1] and the FMP in their early fifties,
with large variations [1, 3, 4].
Around 75% of menopausal women experience hot
flushes [5–7] and 10–20% of postmenopausal women
find these symptoms very bothersome [5]. Some women
also experience night sweats, emotional vulnerability,
sleeping difficulties, fatigue, headache, joint and muscle
pain, cognitive changes, vaginal dryness, and loss of
sexual desire [1, 5, 8–10]. Menopausal symptoms are
commonly experienced for 4–5 years in the years before
and after the FMP; however, for some women the dur-
ation is longer [1, 6, 11].
Menopausal symptoms differ between cultures and
ethnic groups, and also between individuals within a
homogenous population [12, 13]. Therefore, measuring
self-reported menopausal symptoms presents a chal-
lenge, and so does the distinction between menopausal
symptoms and the symptoms of aging. Several question-
naires regarding menopausal symptoms exist. However,
to help women who are bothered by menopausal symp-
toms it requires a PROM that focuses solely on the
bothersome symptoms. Such a PROM must also possess
high content validity as well as adequate psychometric
properties. Item response theory Rasch models is pre-
ferred when establishing ideal measurement psychomet-
ric properties such as unidimensionality, invariance
(specific objectivity or no differential item functioning),
statistical sufficiency and additivity [14–16]. The aims of
this study are threefold: 1) To review existing question-
naires and symptoms checklists (which we also refer to
as questionnaires) measuring bothersome menopausal
symptoms, and, if we cannot identify an adequate exist-
ing questionnaire from the literature search then: 2) To
develop a patient-reported outcome measure (PROM)
for bothersome menopausal symptoms with high
content validity, and: 3) To validate this new PROM for
dimensionality, invariance, known-groups validity, and
reliability using modern psychometric methods.
Methods
The study took place in Denmark and was divided into
three phases: 1) a literature review; 2) qualitative inter-
views securing high face and content validity; 3) a valid-
ation survey where the draft PROM was distributed
cross-sectionally and the data analyzed using classical
test theory (CTT) and item response theory (IRT)
models, securing high construct validity of the final
PROM.
Phase 1:Literature review
A literature search in PubMed, Embase, and the
Cochrane Library was conducted at the end of 2014 and
early 2015 to identify existing questionnaires encom-
passing menopausal symptoms. We also consulted
gynaecologists and general practice specialists to locate
relevant questionnaires. We included questionnaires that
contained at least one item referring to a bothersome
menopausal symptom. Questionnaires on the quality of
life (i.e. no items referring to specific menopausal symp-
toms) or concerning interference with or reaction to
menopausal symptoms were not included. Question-
naires had to be freely available and written in English,
Swedish, Norwegian or Danish. To be interpreted as
adequate, the identified questionnaires should have high
content validity encompassing items that were up-to-
date, not double-barrelled, or ambiguous. Moreover, the
psychometric properties of the questionnaires should be
assessed using IRT.
None of the identified questionnaires fulfilled all the
above criteria. Therefore, we extracted an item-pool
encompassing unique items about solely bothersome
menopausal symptoms from the identified question-
naires. The meaningful content of relevant items was
identified and assessed for redundancy, double-barrelled
items were divided into separate items, and ambiguous
items were rephrased. The items’ response options were
not transferred [17]. The subject matter of these items
was translated into Danish ad-hoc by KSL and JB. The
unique items were grouped into domains by KSL based
on clinical experience and the literature, and these were
subsequently reviewed by JB. Any discrepancies were
discussed until we reached consensus.
Phase 2: Qualitative interviews
To test the content validity (content relevance and con-
tent coverage) and the understandability of the unique
items, two group interviews were conducted with
women bothered by menopausal symptoms. The group
interviews were audio-recorded, they lasted for two
hours, and were moderated by KSL and JB. The first part
of the interview was an open-ended discussion about
bothersome menopausal symptoms. If new themes
(suggested domains) were revealed in the discussion, we
generated new items covering these themes using the
women’s verbatim expressions from the audio recordings
(see below). These new items were tested in the follow-
ing group or in single interviews (see below). In the sec-
ond part of the group interviews, the women were asked
to assess if they found the subject matter of the unique
items relevant. Items found irrelevant were deleted from
the unique item-pool and, in case of lack of content
coverage, new items were generated. We subsequently
asked the women to which of the stated themes
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(suggested domain), their symptoms belonged. A draft
PROM was created after the first group interview. At
the end of the second group interview, the women were
asked to complete the draft PROM. The themes
(suggested domains), a recall period, and suggestions for
response options were discussed. Instructions were
tested for understandability.
Some symptoms postulated to be caused by meno-
pause could also be caused by aging, therefore a global
item was developed: “Have you, within the past three
months, been bothered by menopausal symptoms?”, with
four response options: “no, not at all”, “yes, a bit”, “yes,
quite a bit”, or “yes, a lot”. Later, this global item was
used to evaluate the association between women with
and without bothersome menopausal symptoms and the
scales’ ability to discriminate between the four groups in
the global item: none, mild, moderate, or severe bother-
some menopausal symptoms.
The draft PROM was further tested for functionality,
understandability, and content validity in four single
interviews conducted by KSL. The women included in
these interviews were all bothered by menopausal symp-
toms. A paper version of the draft PROM was tested in
the first two interviews and an online draft version was
tested in the two final interviews. If any problems were
revealed, they were corrected between interviews.
Finally, the online draft PROM was tested for func-
tionality (including the response option) and under-
standability in four individual pilot tests, followed by a
short interview, among women aged 50–64 where two
of the women were bothered by menopausal symptoms.
The group and single interviews were audio-recorded
and we measured the time taken to complete the
PROM. Notes and important citations were listed during
the interviews. After each interview the recording was
audited by KSL and used when the key issues and results
from the interviews were analyzed.
Phase 3: Validation survey and analysis
The final draft PROM was distributed by a link
(SurveyXact) in emails, social media (Facebook groups
for women), project research homepage [18], general
practices, and the women’s lifestyle magazine “Liv” [19]
(through their online newsletter and Facebook page).
Women aged 45–65 years, with and without bothersome
menopausal symptoms, were asked to complete the
PROM.
Reliability and validity To secure adequate psychomet-
ric properties of the final PROM we conducted Rasch
analysis on the data collected verifying if items in each
suggested domain fitted a partial credit Rasch model for
polytomous items [20]. We tested differential item func-
tioning (DIF) [21, 22], i.e. if items performed differently
depending on the variables: occupation, education, living
(living alone), smoking, BMI, age, hormonal intrauterine
device, bilateral ovariectomized, hysterectomized, having
menstruation within the past year. Local dependence
(LD) was also evaluated [15, 23], i.e. whether items were
correlated beyond what could be expected by measuring
the same underlying construct using item screening and
log-linear Rasch model tests [24, 25]. Where evidence of
DIF and/or LD was disclosed, a log-linear Rasch model
was considered indicating a scaling solution with desir-
able measurement properties [14]. Andersen’s condi-
tional likelihood ratio test (CLR-χ2) was used to evaluate
the overall model fit [26] and individual item fit was
assessed by comparing observed and expected rank
correlation between the item and rest-score (sum of
other items in scale) [27]. Items that demonstrated the
most problematic properties and/or poor fit were
deleted stepwise from the scales, until fit of the Rasch
model was achieved. Items with misfit but high face and
content validity it were kept as a single item. Cronbach’s
alpha was used as a measure of reliability [28, 29]. The
Benjamini-Hochberg procedure was used to account for
multiple testing [30].
The sum-scores of the resulting Rasch-fitting scales
(see below) was tested by comparison to the global item.
For each of the four categories of the global item the
means and standard deviations (SD) of the sum-scores
were calculated and compared using ANOVA; also, the
order of the means in a sum-score should reflect the
order of the categories of the global item. We calculated
the number of subjects needed in a hypothetical ran-
domized trial to find, with 80% power, the difference be-
tween the means corresponding to the two last
categories of the global item in a t-test with a signifi-
cance level of 5%; low numbers indicate a high discrim-
inating ability. We used SAS v9.4 and DIGRAM v3.05.3
software.
The study was approved by the Danish Data Agency
(J.nr. 2015–41-4057). Ethics Committee approval was
not required.
Results
Phase 1
We identified 15 questionnaires written in English or
Danish in the literature search, many of which referred
to each other: Kupperman index [31, 32], Modified
Blatt-Kupperman index [33, 34], Greene (1976) [35],
Greene climacteric scale (GCS) [36], WHQ [37, 38],
MENQOL [39], MENQOL-intervention [40], Meno-
pause symptom list (MSL) [41], Menopause rating scale
(MRS) [42], 10-items Cervantes scale (CS-10) [43],
Menopause health state classification [44], Menopause
health questionnaire [4], Neugarten and Kraines [45],
Hvas et al. [46], MQOL [47]. None of the identified
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questionnaires were adequate in relation to all our ad-
equacy criteria: some were not up-to-date [31, 35, 45],
some not sufficiently validated [31, 32, 46] or with miss-
ing information about validation [4, 44]. Some had am-
biguous or double-barrelled items [35, 36, 42], and some
were primarily designed to measure quality of life in
menopausal women [39, 40, 47] or economic evaluations
of the impact of menopause [44], and not just the level
of bothersome menopausal symptoms. None were
assessed using IRT.
These questionnaires had in total 356 items, of which
126 were unique items divided into five domains (Add-
itional file 1: Appendix 1).
Phase 2
The first group interview included five women (aged
50–63 years), and the second included four women
(aged 49–59 years).
In the two group interviews 95 (75.4%) of the 126
items were endorsed and 27 new items (five of these due
to double-barrelled items) and three new domains were
generated (Additional file 1: Appendix 1). In the first
group interview it was revealed that hot flushes and day-
and-night sweats were experienced as two different
things (constructs). Some women were bothered by hot
flushes but did not experience day-and-night sweats.
Others were bothered by both hot flushes and day-and-
night sweats, but described it as different experiences.
This was confirmed in the second group interview.
The women agreed on a three-month recall period
and preferred the four response options; “no, not at all”,
“yes, a bit”, “yes, quite a bit”, or “yes, a lot” (Table 1.
Item layout). In the sexual domain it was decided to cre-
ate an additional response option “I do not know” for re-
spondents not sexually active, with or without a partner.
These preferences were later confirmed in the single in-
terviews. By the end of the second group interview no
new items or domains were generated.
Women interviewed individually were aged 50–52 and
the women who participated in pilot testing were aged
50–64. In these interviews, almost all comments were
about linguistic issues or layout suggestions and only
one extra item was desired and another item perceived
as redundant and deleted. At this point we achieved data
saturation. Finally, one woman requested a comment
box at the end of the PROM. Table 2 presents the num-
ber and age of participants in the interviews. The final
version of the draft PROM encompassed 122 items cov-
ering 8 domains (Additional file 2: Appendix 2) and
took, on average, 10 min to complete.
Phase 3
Survey
Within 48 h 1511 women had completed the draft
PROM. Seven completed questionnaires were excluded;
six respondents were under the age of 45 years and one
respondent had ambiguous and inconsistent responses.
The characteristics of the remaining 1504 respondents
are listed in Tables 2 and 3.
Psychometric analysis
The analyses revealed eleven uni-dimensional scales fit-
ting a Rasch model. One single item was retained due to
high face validity.
The final PROM was named the MenoScores Ques-
tionnaire (MSQ) and the eleven scales cover the con-
structs: hot flushes (HF), 2 items; day-and-night sweats
(DNS), 2 items; general sweating (GS), 2 items;
menopausal-specific sleeping problems (MSSP), 2 items;
emotional (EM), 12 items; memory (MEM), 2 items;
skin-hair (SH), 8 items; physical (PHY), 8 items; abdom-
inal (ABD), 4 items; urinal-vaginal (URIN), 4 items, and
sexual (SEX), 4 items. Including the retained single item
(more tired than usual) the MSQ encompasses 51 items
in total. Item numbers are listed in Table 4.
Vasomotor symptoms
This suggested six-item domain showed misfit. Based on
evidence of LD and results from the qualitative inter-
views, where hot flushes and day-and-night sweats were
described as two different constructs, three two-item
scales were formed. These scales all fitted a Rasch model
and had no evidence of LD and were named: hot flushes
(HF), day-and-night sweats (DNS) and general sweating
(GS).
In the HF scale, item 4 (hot flushes during the day)
showed DIF with respect to (wrt.) having menstruation
within the past year (p = 0.0013), and item 5 (hot flushes
during the night) showed DIF wrt. BMI (p = 0.0008). In
the DNS scale, item 6 (sweats during the day) showed
DIF wrt. BMI (p < 0.0001), and item 7 (night-sweats)
showed DIF wrt. Having menstruation within the past
year (p = 0.0045). In the GS scale there was no evidence
of DIF.
Sleep
The suggested 10-item domain did not fit a Rasch
model. A two-item menopausal-specific sleeping problems
Table 1 Example of item layout and response options
Have you – within the past three months – experienced the following
symptoms?
No, not
at all
Yes, a bit Yes, quite a bit Yes, a lot
I have had hot flushes
during the day
I have had hot flushes
during the night
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(MSSP) scale was found to fit a Rasch model with no
evidence of DIF or LD.
Emotional
The suggested 36-item domain did not fit a Rasch
model. We omitted poor fitting items and found a 12-
item EM scale (items 22, 27, 30, 31, 33, 34, 40, 43, 45,
47, 48, 53) with adequate fit to the partial credit Rasch
model, but with substantial evidence of LD. The LD sug-
gests four clusters of items: depression (three items: 22
[been depressed], 27 [mood swings], 34 [worried about
nervous breakdown]); anxiety (three items: 30 [felt anx-
iety], 31 [felt nervous], 33 [needlessly worried]); social
(two items: 40 [less confidence], 45 [felt isolated]), and
energy (four items: 43 [no energy to socialize], 47 [do
less], 48 [can accomplish less] 53 [difficulty concentrat-
ing]). No satisfactory log-linear Rasch model could be
identified.
We analyzed items 54 and 55 separately because of high
content validity and because the content seemed different
from the remaining items. They formed the Memory
(MEM) scale where no DIF or LD was revealed.
Skin, hair and mucosa
This suggested 15-item domain did not fit a Rasch
model, but an eight-item scale (58, 62, 63, 64, 65, 66, 67,
69), the skin-hair (SH) scale, was found to fit the log-
linear Rasch model. Evidence of LD was disclosed for
three item pairs: 62 (crawling feeling over the skin) and
63 (itching of the scalp); 64 (vaginal dryness) and 65 (va-
ginal itching); 66 (shed more hair than usual) and 67
(nails split more than usual). Item 62 showed DIF wrt.
Smoking; item 64 showed DIF wrt. Age and wrt. Having
menstruation within the past year, and item 65 showed
DIF wrt. Having menstruation within the past year.
Physical
This suggested physical 41-item domain was divided into
3 hypothesized scales due to the content of the items:
physical (PHY), 25 items; abdominal (ABD), 10 items,
and urinary-vaginal (URIN), 6 items.
Physical (PHY) scale.
This 25-item scale was rejected, but a scale with eight
items (71, 73, 75, 76, 80, 84, 86, 95) was found to fit the
log-linear Rasch model where evidence of LD was found
for the three item pairs 71 (heart palpitation) and 76
(been dizzy); 73 (headache) and 84 (neck pain); 80 (sore
joints) and 86 (pins and needles in feet). Furthermore,
item 73 showed DIF wrt. Age and item 80 showed DIF
wrt. BMI.
Abdominal (ABD) scale
This 10-item scale was rejected, but a 4-item scale com-
prising the items 77, 96, 98, and 102 was found to fit a
log-linear Rasch model. In this scale, LD was found
between item 77 (nausea) and item 98 (uncontrollable
loss of gas). Item 96 (bloated stomach) showed DIF wrt.
Age and item 98 showed DIF wrt. Education.
Urinary-vaginal (URIN) scale
The 6-item scale was rejected, but a 4-item scale
comprising the four items 106, 107, 108, and 110 was
obtained. Item 108 (urine smells different) showed DIF
wrt. Smoking and LD was found between item 106 (need
to pass urine more frequently) and 107 (sometimes leak
urine), and between 108 (urine smells different) and 110
(vaginal discharge has been different).
Item 91 (more tired than usual) did not fit any of the
scales. The item was also tested with the MSSP scale but
without a fit to a Rasch model. Finally, the item was
tested with the three related items 92, 93, and 94 but
they did not fit a Rasch model. Nevertheless item 91 was
retained as a single item because of its high face validity.
Sexual
Four items (115, 116, 117, 118) from this domain fitted a
Rasch model and were named the sexual (SEX) scale.
LD was found between the items 115 (pain during inter-
course) and 116 (bleeding after intercourse). Item 115
showed DIF wrt. Age and being bilaterally ovariecto-
mized and item 116 showed DIF wrt. Having a hormonal
intrauterine device and having menstruation within the
past year; while item 117 (too tired for sex) showed DIF
wrt. Living alone.
The SH, ABD scales showed signs of dichotomization
in the category probability curves. The SH, ABD and
SEX (with the additional response option “I do not
know”) scales were re-tested in three single interviews
Table 2 Number and age of participants (BMS = bothersome menopausal symptoms)
Number Number with/without BMS Age (women with BMS)
Mean (range)
Age (women without BMS)
Mean (range)
Group interviews 9 9/0 52.89 (49–63) –
Single interviews 4 4/0 50.75 (50–52) –
Pilot test 4 2/2 52 (50–54) 63 (62–64)
Survey (cross
sectional)
1504 1073/431 51.97 (45–65) 50.69 (45–65)
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(with women age 50 to 65) and all women preferred the
three-response option instead of four (“no, not at all”,
“yes, a bit”, or “yes, a lot”, plus the additional option in the
SEX scale). In order to optimize model fit, the response
options in these scales were reduced to the three options
above (including the addition option in the SEX scale).
Work and spare time
Two-thirds of respondents were asked to complete this
domain (i.e. women who claimed to be bothered by meno-
pausal symptoms by answering “yes” to the global item).
The 3-item domain fitted a Rasch model (p = 0.117) but
items 1 and 3 with extremely poor item fit (p = 0.0001)
and (p = < 0.0001). Thus, we decided to exclude this
domain from the final PROM.
Menstruation
Only women who had menstruated within the past year
were asked to complete this domain (approximately half
of the respondents) (Table 3). This suggested 3-item
domain did not fit a Rasch model (p = 0.000) and the
items were not included in the final PROM.
Association (discrimination)
The HF, DNS, GS, and MSSP scales showed best perform-
ance in discriminating between the response options of
the global item (Fig. 1. HF, DNS, GS, MSSP scales). The
discriminating ability is presented in Table 5.
Reliability
The reliability of the scales was moderate to high with
Cronbach’s alpha values between 0.60 and 0.91 (Table 5).
Table 4 presents individual item fit and Table 5 presents
fit statistics, Cronbach’s alpha, and discriminating ability.
Discussion
We found that all existing questionnaires lacked content
validity regarding bothersome menopausal symptoms
and none were validated using IRT. Moreover, they all
Table 3 Characteristics of respondents (survey)
Characteristics/
exogenous variables
Total no.
(% of total)
Bothersome
menopausal symptoms
No. (%)
Total 1504 (100) 1073 (71.34)
Age (years):
45–48 394 (26.20) 209 (53.05)
49–52 543 (36.10) 417 (76.80)
53–55 304 (20.21) 264 (86.84)
56–60 205 (13.63) 154 (75.12)
61–65 58 (3.86) 29 (50.00)
BMI
0–18 10 (0.67) 8 (80.00)
19–24 682 (45.77) 469 (68.77)
25–29 518 (34.77) 379 (73.17)
≥ 30 280 (18.79) 206 (73.57)
Missing 14
Occupationa
Yes 1250 (83.11) 893 (71.44)
No 75 (4.99) 50 (66.67)
Sick leave 51 (3.39) 34 (66.67)
Retired or similar 128 (8.51) 96 (75.00)
Education
No education 56 (3.73) 41 (73.21)
Skilled worker, apprentice,
assistant nurse or likewise
273 (18.16) 206 (75.46)
Short higher educationb <
3 years
213 (14.17) 167 (78.40)
Medium higher education
3–4 years
633 (42.12) 449 (70.93)
Long higher education >
4 years
233 (15.50) 141 (60.52)
Other 90 (5.99) 63 (70.00)
Do not know 5 (0.33) 5 (100)
Missing 1
Living alone
Yes 310 (20.78) 214 (69.03)
No 1182 (79.22) 851 (72.00)
Missing 12
Smoking
Yes 238 (15.82) 179 (75.21)
No 1266 (84.18) 894 (70.62)
Gynecological history
Hormonal intrauterine device
Yes 247 (16.42) 144 (58.30)
No 1257 (83.58) 929 (73.91)
Bilateral ovariectomized
Yes 40 (2.66) 32 (80.00)
Table 3 Characteristics of respondents (survey) (Continued)
Characteristics/
exogenous variables
Total no.
(% of total)
Bothersome
menopausal symptoms
No. (%)
No 1464 (97.34) 1041 (71.11)
Hysterectomized
Yes 121 (8.05) 95 (78.51)
No 1383 (91.95) 978 (70.72)
Having menstruation within the past year
Yes 717 (47.67) 464 (64.71)
No 787 (52.33) 609 (77.38)
aOccupation Employed, working or studying. bhigher education = education
after high school or likewise
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Table 4 Individual item fit
Item no. Item wording A priori domain Final scale Fit to Rasch model Fit to log linear
Rasch model
Observed Expected P Observed Expected P
4 I have had hot flushes during the day D2 - Vasomotor HF 0.824 0.823 0.9107 0.821 0.820 0.9157
5 I have had hot flushes during the night D2 - Vasomotor HF 0.824 0.823 0.9107 0.821 0.820 0.9157
6 I have had bouts of sweating during the
day
D2 - Vasomotor DNS 0.694 0.691 0.8768 0.694 0.691 0.8757
7 I have had bouts of night sweats D2 - Vasomotor DNS 0.694 0.691 0.8768 0.694 0.691 0.8757
8 I have been sweating more than usual. D2 - Vasomotor GS 0.632 0.633 0.9720 0.632 0.633 0.9628
9 I have had cold sweats D2 - Vasomotor GS 0.632 0.633 0.9720 0.632 0.633 0.9628
10 I have not been able to sleep because of
night sweats
D3 - Sleep MSSP 0.872 0.870 0.8853 – – –
11 I have not been able to sleep because of
hot flushes
D3 - Sleep MSSP 0.872 0.870 0.8853 – – –
22 I have been depressed D4 - Emotional EM 0.717 0.680 0.0360 – – –
27 I have had mood swings D4 - Emotional EM 0.646 0.677 0.0545 – – –
30 I have felt anxiety D4 - Emotional EM 0.690 0.693 0.9022 – – –
31 I have felt nervous D4 - Emotional EM 0.696 0.680 0.3557 – – –
33 I have been needlessly worried D4 - Emotional EM 0.667 0.678 0.5050 – – –
34 I have been worried about having a
nervous breakdown
D4 - Emotional EM 0.727 0.700 0.1399 – – –
40 I have had less confidence D4 - Emotional EM 0.677 0.687 0.5561 – – –
43 I have not had the energy to socialize D4 - Emotional EM 0.671 0.677 0.7186 – – –
45 I have felt isolated D4 - Emotional EM 0.689 0.693 0.7989 – – –
47 I have done less than I would like D4 - Emotional EM 0.694 0.681 0.3996 – – –
48 I can accomplish less than I used to D4 - Emotional EM 0.680 0.682 0.9221 – – –
53 I have had difficulty concentrating D4 - Emotional EM 0.682 0.683 0.9548 – – –
54 My memory has been worse than usual D4 - Emotional MEM 0.923 0.923 0.9841 – – –
55 I have had problems with remembering
everyday things
D4 - Emotional MEM 0.923 0.923 0.9841 – – –
58 I have had dry skin D5 - Skin, hair and
mucosa
SH 0.462 0.411 0.0273 0.462 0.351 <
0.0001
62 I have had a crawling feeling over the skin D5 - Skin, hair and
mucosa
SH 0.411 0.418 0.8215 0.409 0.445 0.2133
63 I have had itching of the scalp D5 - Skin, hair and
mucosa
SH 0.436 0.405 0.2111 0.436 0.416 0.4045
64 I have had vaginal dryness D5 - Skin, hair and
mucosa
SH 0.418 0.431 0.5544 0.417 0.463 0.0378
65 I have had vaginal itching D5 - Skin, hair and
mucosa
SH 0.475 0.405 0.0131 0.474 0.478 0.8649
66 I have shed more hair than usual D5 - Skin, hair and
mucosa
SH 0.417 0.421 0.8541 0.417 0.418 0.9889
67 My nails split more than usual D5 - Skin, hair and
mucosa
SH 0.364 0.425 0.0128 0.371 0.423 0.0337
69 I have more body hair growth D5 - Skin, hair and
mucosa
SH 0.333 0.412 0.0062 0.333 0.346 0.6786
71 I have had heart palpitations D6 - Physical PHY 0.468 0.491 0.3039 0.468 0.491 0.3039
73 I have had headache D6 - Physical PHY 0.461 0.496 0.0934 0.461 0.496 0.0934
75 I have had a blind spot in front of my eye D6 - Physical PHY 0.510 0.510 0.9896 0.510 0.510 0.9896
76 I have been dizzy D6 - Physical PHY 0.533 0.485 0.0396 0.533 0.485 0.0396
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regarded hot flushes and day-and-night sweats as a sin-
gle construct, which this study could not confirm. We
found that the suggested vasomotor domain was three-
dimensional concluding that hot flushes and day-and-
night sweats are two different constructs. This was
revealed in the qualitative interviews and confirmed by
the Rasch analysis. Furthermore, these findings were
confirmed when screening potential participants for a
current randomized controlled trial (RCT) [48]. This
study also revealed that only some symptoms are
unquestionably related to the menopausal transition and
four constructs are of importance when measuring
bothersome menopausal symptoms: hot flushes, day-
and-night sweats, general sweating and menopausal-
specific sleeping problems.
A strength of this study is the combination of rigorous
qualitative and quantitative processes. Through the
qualitative interviews we secured high content validity.
Subsequently we used Rasch models to assess if the
suggested domains behaved psychometrically as we
expected. Another strength is the assessment of discrim-
inating ability. Using the responses to the global item, in
relation to the responses to the remaining items, we
assessed how well the individual scales within the MSQ
discriminated between the response options of the global
item. We found the HF, DNS, GS and MSSP scales
performed best in discriminating. Our interpretation of
this is that only these constructs (HF, DNS, GS, MSSP)
are unquestionably related to the menopausal transition.
Many other symptoms may be, more or less, caused by
aging.
A limitation could be that as the data was collected
cross-sectionally, test-retest analysis is not reported.
Women with bothersome menopausal symptoms report
fluctuations in their symptoms from day-to-day. There-
fore, a test-retest with a 2-week interval would not be
meaningful. Instead we assessed the internal consistency
of the scales using Cronbach’s alpha. A further limitation
is the broad sampling procedure which makes it difficult
to know exactly what population the sample is represen-
tative of, due to the element of self-selection inherent in
survey data using web-based enrolment. The fact that
Rasch validation is performed without distributional
assumptions mitigates this challenge.
We identified DIF and LD in some of the final scales
which may limit MSQ’s applicability in some situations.
Items 4 and 5 from the HF scale and items 6 and 7 from
the DNS scale all possessed DIF. Nevertheless, these
items were maintained because of their high face vali-
dity. If the developed scales are used in a RCT, DIF is far
less problematic because any exogenous variables will
presumably be equally distributed among the randomized
Table 4 Individual item fit (Continued)
Item no. Item wording A priori domain Final scale Fit to Rasch model Fit to log linear
Rasch model
80 One or more of my joints has been sore D6 - Physical PHY 0.528 0.513 0.4367 0.528 0.513 0.4367
84 I have had neck pain D6 - Physical PHY 0.530 0.518 0.5332 0.530 0.518 0.5332
86 I have had pins and needles in my feet D6 - Physical PHY 0.546 0.527 0.4502 0.546 0.527 0.4502
95 I have been more clumsy than usual D6 - Physical PHY 0.505 0.506 0.9606 0.505 0.506 0.9606
77 I have had nausea D6 - Physical ABD 0.421 0.464 0.1331 0.421 0.464 0.1331
96 My stomach has tended to be bloated D6 - Physical ABD 0.500 0.476 0.2837 0.500 0.476 0.2837
98 I have had uncontrollable loss of gas D6 - Physical ABD 0.507 0.472 0.1474 0.507 0.472 0.1474
102 My stool has been loose D6 - Physical ABD 0.453 0.466 0.6507 0.453 0.466 0.6507
106 I need to pass urine more frequently than
usual
D6 - Physical URIN 0.532 0.481 0.03241 0.532 0.492 0.0975
107 I sometimes leak urine D6 - Physical URIN 0.459 0.474 0.55320 0.459 0.489 0.2257
108 My urine has smelled different D6 - Physical URIN 0.511 0.482 0.28580 0.511 0.462 0.0770
110 My vaginal discharge has been different D6 - Physical URIN 0.419 0.483 0.03539 0.419 0.477 0.0569
115 I have had pain during intercourse D7 - Sexual SEX 0.701 0.629 0.0010 0.701 0.676 0.2232
116 I have had bleeding after intercourse D7 - Sexual SEX 0.714 0.699 0.5665 0.714 0.764 0.0222
117 I have been too tired for sex D7 - Sexual SEX 0.579 0.580 0.9703 0.579 0.550 0.1721
118 I have had difficulty achieving an orgasm D7 - Sexual SEX 0.535 0.576 0.0554 0.535 0.544 0.6740
91 I have felt more tired than usual D6 - Physical Single
item
– – – – – –
HF = hot flushes (2 items), DNS = day-and-night sweats (2 items), GS = general sweating (2 items), MSSP =menopausal-specific sleeping problems (2 items), EM =
emotional (12 items), MEM =memory (2 items), SH = skin-hair (8 items), PHY = physical (8 items), ABD = abdominal (4 items), URIN = urin-vaginal (4 items), SEX =
sexual (4 items)
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groups. However, if the scales are used in non-randomized
studies, and any exogenous variables that can cause
DIF appear in the studied cohort, one should adjust for
the magnitude of the identified DIF [22]. Another ap-
proach would be to refrain from items possessing DIF
or refrain from using the scales encompassing items
possessing DIF [22].
Scales with many items may be preferred, since many
items in a scale could increase the sensitivity, specificity,
reliability, and ability to discriminate between the groups
Fig. 1 HF, DNS, GS, MSSP scales
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being tested. In the present study, our interest was to as-
sess if the women were “not at all”, “a bit”, “quite a bit”,
or “a lot” bothered by menopausal symptoms. We found
the best discriminating scales among four 2-item scales:
the vasomotor and sleeping scales (HF, DNS, GS and
MSSP) and not among scales encompassing more items.
There could be two reasons for this lack of discrimin-
ation: 1) LD, but even after deleting items with LD, these
scales still did not discriminate as well as the scales from
the vasomotor and sleeping domains; 2) that the subject
matter of the other scales is related more to aging than
to menopause.
Due to the large item-pool we identified, we could dis-
charge problematic and poor fitting items using a step-
wise procedure. However, we ensured that no important
items were lost just because of a psychometric misfit.
Therefore, items with high content validity but psycho-
metric misfit were kept as a single item, e.g. item 91
(more tired than usual).
Even though the “work and spare time” domain fitted
a Rasch model the items showed poor item fit. Since
these items were not symptoms in themselves, but re-
ferred to how menopausal symptoms affected women’s
work and spare time, we decided to disband these items
and omit this domain from the final PROM. Moreover,
the 3-item menstruation domain did not fit a Rasch
model, and as these items were not of high relevance to
this study, they were excluded from the final PROM.
Since the timing of menopause and the experience of
menopausal symptoms vary so widely [1, 4], the MSQ is
designed to measure self-reported bothersome meno-
pausal symptoms both in peri- and post-menopausal
women. The intention is for the MSQ to be used as an
outcome measure in studies where women are treated
for bothersome menopausal symptoms. The time needed
to complete the MSQ is estimated at 5 min, as the MSQ
contains fewer than half the items in the draft PROM.
The MSQ only addresses bothersome menopausal
symptoms since these would be the target for treat-
ment. It is important to note that some women also
have positive experiences in relation to the meno-
pause [49]; however, this is beyond the scope of the
present study. The MSQ was developed in Danish
and any new language or modified version may need
an additional validation study to secure adequate
measurement properties.
Table 5 Fit statistics, the Cronbach’s alpha and discriminating ability of the scales included in the MSQ
Scale Number
of
items
Fit to Rasch model Fit to log linear Rasch model Cronbach’s
alpha
discriminating abilitya
χ2 df P χ2 df P
Vaso-motor 6 91.9 17 < 0.0001 – – – 0.90
1. HF 2 6.1 5 0.2941 19.7 26 0.8057 0.85 30
2. DNS 2 9.9 5 0.0778 21.6 25 0.6588 0.76 34
3. GS 2 13.6 5 0.0183 13.2 17 0.7225 0.60 62
MSSP 10 308.2 29 < 0.0001 – – – 0.90
4. MSSP 2 6.0 5 0.3077 – – – 0.87 42
Emotional 36 511.4 107 < 0.0001 – – – 0.97
5. EM 12 45.1 35 0.1189 – – – 0.93 158
6. MEM 2 2.9 5 0.7176 – – – 0.90 258
SH 15 137.3 44 < 0.0001 0.81
7. SH 8 27.7 23 0.2289 61.5 71 0.7828 0.71 300
Physical 25 768.6 74 < 0.0001 0.93
8. PHY 8 25.1 23 0.3433 87.2 73 0.1235 0.79 218
Abdominal 10 219.0 29 < 0.0001 0.81
9. ABD 4 13.2 11 0.2822 33.4 47 0.9260 0.63 522
Urinary 6 65.8 17 < 0.0001 0.74
10. URIN 4 18.7 11 0.0674 7.0 32 1.0000 0.67 1040
Sexual 8 230.4 31 < 0.0001 0.95
11. SEX 4 15.8 15 0.3981 37.6 58 0.9825 0.91 320
aTotal number of responders needed to show a clinically relevant difference in symptoms (moderate vs. severe bothersome menopause-related symptoms) with
an 80% power and 5% level of significance. Low numbers indicate a high discriminating ability.
df = Degrees of freedom, HF = hot flushes, DNS = day-and-night sweats, GS = general sweating, MSSP =menopausal-specific sleeping problems, EM = emotional,
MEM =memory, SH = skin-hair, PHY = physical, ABD = abdominal, URIN = urin-vaginal, SEX = sexual
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Conclusion
Menopausal symptoms are multidimensional with only
some symptoms unquestionably related to the meno-
pausal transition. The MenoScores Questionnaire
(MSQ) is a new, condition-specific PROM with high
content validity and adequate psychometrical properties
measuring bothersome menopausal symptoms. To the
best of our knowledge this is the first PROM measuring
only bothersome menopausal symptoms, wherein all
scales are developed via interviews with women having
bothersome menopausal symptoms and thereafter psy-
chometrically validated using IRT Rasch Models. The
focus on bothersome symptoms will assist with identify-
ing and evaluating treatments for women bothered by
menopausal symptoms.
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